Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
IN VITRO AND IN VIVO ASSESSMENT OF BUPRENORPHINE EXTENDED RELEASE INJECTIONS FOR GENERIC PRODUCT EQUIVALENCE
Task order obligations
Estimated months remaining until end of performance.
Period of performance
90% of period elapsed
Awarding Agency
FAFOOD AND DRUG ADMINISTRATION
Code: 7524
Funding Agency
FAFOOD AND DRUG ADMINISTRATION
Code: 7524
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|